Project Updates



Location: Charlottetown, Prince Edward Island, Canada 
Project type: mRNA Vaccine and Biomanufacturing Centre 
Announced: November 2021 
Construction Started: April 2022

BIOVECTRA, a biotech and pharmaceutical company, is building a new facility to produce and manufacture messenger ribonucleic acid (mRNA) vaccines and therapeutics at its Charlottetown campus in Canada.

AGC Biologics

Credit: AGC Biologics

Location: Heidelberg, Germany 
Project type: Manufacturing Facility Expansion 
Announced: September 2021 
Completion: October 2023 

AGC Biologics (AGC), a contract development and manufacturing organisation (CDMO) based in the US, has expanded its facility in Heidelberg, Germany, to increase its plasmid DNA (pDNA) and messenger RNA (mRNA) manufacturing capabilities.

Novo Nordisk

Credit: Novo Nordisk

Location: Kalundborg, Denmark 
Project type: Active pharmaceutical ingredients (API) manufacturing facility 
Estimated Investment: More than DKr42bn ($6bn) 
Area: 170,000m²

Novo Nordisk, a pharmaceutical company based in Denmark, announced plans in November 2023 to expand its existing manufacturing capacity by building a new active pharmaceutical ingredients (API) facility in Kalundborg, Denmark.